Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US Stocks Movement | European Bank Stocks Mostly Decline, Deutsche Bank (DB.US) Down 5%

US Stocks Movement | European Bank Stocks Mostly Decline, Deutsche Bank (DB.US) Down 5%

智通财经智通财经2026/10/07 14:36
Show original

On Wednesday, European bank stocks generally declined, with Deutsche Bank (DB.US) falling by 5% and HSBC Holdings (HSBC.US) dropping by 4%.

According to Golden Ten Data APP, on Wednesday, European bank stocks fell across the board. Deutsche Bank (DB.US) dropped 5%, HSBC Holdings (HSBC.US) fell 4%, and Santander Bank (SAN.US) declined by more than 3%. Major U.S. bank stocks also followed with declines, as Goldman Sachs (GS.US) lost nearly 3%, Citigroup (C.US) fell more than 2%, while JPMorgan (JPM.US), Wells Fargo (WFC.US), Morgan Stanley (MS.US), and Bank of America (BAC.US) each dropped over 1%.

In terms of news, on October 7 local time, the STOXX Europe Banks Index followed a sell-off in sovereign bonds, sharply falling during the trading session with a maximum drop of around 3.5%, hitting a new low since July. The balance sheets of major European banks hold a large amount of eurozone sovereign bonds. The rapid drop in the bond market brings unrealized losses on bonds available for sale, and investors are worried about erosion of capital buffers—this is the most direct impact.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks